0001493152-24-027251.txt : 20240715 0001493152-24-027251.hdr.sgml : 20240715 20240715110935 ACCESSION NUMBER: 0001493152-24-027251 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240627 FILED AS OF DATE: 20240715 DATE AS OF CHANGE: 20240715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GREEN DAVID CENTRAL INDEX KEY: 0001008643 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35853 FILM NUMBER: 241116188 MAIL ADDRESS: STREET 1: C/O HARVARD BIOSCIENCE INC STREET 2: 84 OCTOBER HILL ROAD CITY: HOLLISTON STATE: MA ZIP: 01746-1371 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc. CENTRAL INDEX KEY: 0001563665 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 455210462 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL ROAD STREET 2: SUITE 11 CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: (774) 233-7300 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD STREET 2: SUITE 11 CITY: HOLLISTON STATE: MA ZIP: 01746 FORMER COMPANY: FORMER CONFORMED NAME: Biostage, Inc. DATE OF NAME CHANGE: 20160331 FORMER COMPANY: FORMER CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc. DATE OF NAME CHANGE: 20121204 4 1 ownership.xml X0508 4 2024-06-27 0 0001563665 Harvard Apparatus Regenerative Technology, Inc. HRGN 0001008643 GREEN DAVID C/O HREGEN 84 OCTOBER HILL ROAD, SUITE 11 HOLLISTON MA 01746 1 0 0 0 0 Stock Option (right to buy) 2.92 2024-06-27 4 A 0 10204 0 A 2034-06-27 Common Stock, par value $0.01 per share 10204 10204 D Stock Option (right to buy) 2.92 2024-06-27 4 A 0 8215 0 A 2034-06-27 Common Stock, par value $0.01 per share 8215 8215 D This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 27, 2024, December 27, 2024, March 27, 2025 and June 27, 2025. This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2024, September 30, 2024 and December 31, 2024. This form has been signed under power of attorney. /s/ Joseph Damasio, by power of attorney 2024-07-15